RMEL3 and neoplasm: Survival curves calculated using Kaplan-Meier method show that lack of RMEL3 expression in the tumor correlates with poor survival rates, with most deaths occurring within 2.2 years of follow up, an interval in which all ten patients with detectable expression were still alive (Figure 3C).